S21 Advisory offers consulting services to life science companies and investors with focus on clinical development & regulatory strategy, due diligence, investment analysis and business development.
Examples:
*Strategic Development
Regulatory and Clinical Development Strategy
New indication or product planning
Business case development and challenge
* Due diligence
Investment decisions, valuation
Turnaround strategies
* Capital Markets Strategy
Investor Relations
Pitch deck development
Experience with Series A-B, IPO
Management, compliance and delisting of a U.S. public company
* Interim or project management
Executive Level / Managing Director
R&D organization
* Non-executive board director or board advisor
Currently working in: amyotrophic lateral sclerosis, major depressive disorder.
Previous experience in: multiple sclerosis, Friedreichs Ataxia, psoriasis, major depressive disorder, bipolar disorder, diabetes mellitus and obesity.
Feel free to reach out for a discussion on how I can help you at claus@s21advisory.com / +45 81771250.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2023
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was S21 Advisory founded?
S21 Advisory was founded in 2023.
What industry is S21 Advisory in?
S21 Advisory operates in Business Consulting and Services. Find similar Business Consulting and Services investors on gritt.io.
Where is S21 Advisory based?
S21 Advisory is headquartered in Copenhagen, Denmark.
Find investors for your startup like S21 Advisory
Gritt sends AI-personalised outreach to each investor — from your Gmail
